Store at 20°C to 25°C (68°F to 77°F). See USP controlled room temperature. Protect from freezing. In case of accidental ingestion contact a Poison Control Center immediately. Keep container tightly closed. You may report side effects by calling the FDA at 1-800-FDA-1088
Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser is indicated in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.
CAUTION
USER SAFETY WARNINGS SECTION
If redness or irritation occurs, discontinue use.
Call your doctor for medial advice about side effect.
DOSAGE & ADMINISTRATION SECTION
Wash affected areas once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and leberally apply to areas to be cleansed, massage gently into skin for 10-20 seconds working into a full leather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing cleanser off sooner or using less often.
FOR EXTERNAL USE ONLY. NOT FOR INTRAVAGINAL OR OPTHALMIC USE. (KEEP AWAY FROM EYES).
KEEP OUT OF REACH OF CHILDREN
(Shake well before use)
STORAGE AND HANDLING SECTION
Store at 20°C to 25°C (68°F to 77°F). See USP controlled room temperature. Protect from freezing.
In case of accidental ingestion contact a Poison Control Center immediately. Keep container tightly closed.
You may report side effects by calling the FDA at 1-800-FDA-1088
DESCRIPTION SECTION
Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Chemically sodium sulfacetamide is N-[(4-aminophenyl)sulfonyl]-acetamide monosodium salt, monohydrate. The structural formula is:
Structure
CLINICAL PHARMACOLOGY SECTION
The most widely accepted mechanism of action of sulfonamides is the woods-fields theory which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological halflife has variously been reported as 7 to 12.8 hours. The exact mode of action of sulfur in the treatment of acne is unknown but it has been reported that it inhibits the growth of propionibacterium acnes and the formation of free fatty acids.
CONTRAINDICATIONS SECTION
Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser is contraindicated for use by patients having known hypersensitivity to sulfonamides, sulfur or any other component of this preparation. Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser is not to be used by patients with kidney disease.
WARNINGS SECTION
Although it is rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice, and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.
GENERAL
PRECAUTIONS SECTION
If irritation develops, use of the product should be discontinued and appropriate therapy instituted. Patients should be carefully observed for possible local irritation or sensitization during long-term therapy. The object of this therapy is to achieve desquamation without irritation, but sodium sulfacetamide and sulfur can cause reddening and scaling of the epidermis. These side effects are not unusual in the treatment of acne vulgaris, but patients should be cautioned about the possibility.
INFORMATION FOR PATIENTS
INFORMATION FOR PATIENTS SECTION
Avoid contact with eyes, eyelids, lips and mucous membranes. If accidental contact occurs, rinse with water. If excessive irritation develops, discontinue use and consult your physician.
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY
CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION
Long-term studies in animals have not been performed to evaluate carcinogenic potential.
PREGNANCY Category C
PREGNANCY SECTION
Animal reproduction studies have not been conducted with Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser. It is also not known whether Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser should be given to a pregnant woman only if clearly needed.
PEDIATRIC USE
PEDIATRIC USE SECTION
Safety and effectiveness in children under the age of 12 have not been established.
NURSING MOTHERS
NURSING MOTHERS SECTION
It is not known whether sodium sulfacetamide is excreted in the human milk following topical use of Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser. However, small amounts of orally administered sulfonamides have milk. In view of this and because many drugs are excreted in human milk, caution should be exercised when Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser is administered to a nursing woman.
ADVERSE REACTIONS SECTION
Although rare, sodium sulfacetamide may cause local irritation.
HOW SUPPLIED SECTION
Sodium Sulfacetamide 9.8% & Sulfur 4.8 % Cleanser is available in
10 oz (285 g) bottle, NDC 87026-205-10.
SPL UNCLASSIFIED SECTION
This bottle is not filled to the top but does contain 10 oz of product as identified on the front panel of the bottle.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.